Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance. [PDF]
Khan MT +4 more
europepmc +1 more source
Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network
Dissanayake D +5 more
europepmc +1 more source
Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis. [PDF]
Iwamoto T +11 more
europepmc +1 more source
Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru. [PDF]
Calderón RI +10 more
europepmc +1 more source
Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. [PDF]
Sengstake S +8 more
europepmc +1 more source
Management of <i>Mycobacterium bovis</i> Meningitis: The Case for Adjunctive Empirical Therapy. [PDF]
Birabaharan M, Cowell AN.
europepmc +1 more source
Global and Regional Patterns of Drug Resistance and Treatment Regimens in Spinal Tuberculosis: A Systematic Review and Meta-Analysis. [PDF]
Rajasekaran S +10 more
europepmc +1 more source
Algorithmic Determinants of Performance Heterogeneity in Whole-Genome Sequencing-Based Prediction of Drug Resistance in <i>Mycobacterium tuberculosis</i>: A Systematic Review and Meta-Analysis. [PDF]
Peng B +7 more
europepmc +1 more source
National genomic survey of drug-resistance and multi-jurisdictional clusters of <i>Mycobacterium tuberculosis</i> in Australia 2015-2023. [PDF]
Webb JR +27 more
europepmc +1 more source

